Total Funding
49
39
Total FundingVenture - Series Unknown raised
Growth Score 49 in past quarter
-2 pts
Heat Score 39 in past quarter
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
173575
Tangram Therapeutics focuses on the discovery of cancer and degenerative diseases of the nervous system.
Trevor Jones: ProfessorPast Role: ReNeuron Group, Founder, Director & Former Chairman
Karl Keegan: Chief Financial Officer
About the Company
Tangram Therapeutics is a drug discovery and development company. It has developed proprietary computational systems to swiftly and accurately analyse and predict how medicines interact with cells in the body in hopes of optimizing the probability of identifying drug candidates with desirable efficacy and minimal side effects.